Dong Dong Selected Research

Dong Dong Research Topics

Disease

32	Neoplasms (Cancer) 01/2022 - 05/2008
9	Breast Neoplasms (Breast Cancer) 07/2022 - 11/2017
9	Neoplasm Metastasis (Metastasis) 07/2022 - 05/2008
7	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 05/2011
7	Infections 08/2020 - 12/2015
5	Colorectal Neoplasms (Colorectal Cancer) 02/2022 - 05/2008
4	Alzheimer Disease (Alzheimer's Disease) 10/2019 - 01/2017
3	Lung Neoplasms (Lung Cancer) 01/2022 - 06/2019
3	Inflammation (Inflammations) 09/2021 - 02/2015
3	Rhinosinusitis 12/2020 - 06/2014
3	Memory Disorders (Memory Loss) 10/2019 - 06/2017
3	Autoimmune Diseases (Autoimmune Disease) 09/2017 - 02/2015
3	Renal Cell Carcinoma (Grawitz Tumor) 08/2017 - 01/2014
2	Circulating Neoplastic Cells 06/2022 - 01/2020
2	Hemophilia A (Haemophilia) 05/2022 - 01/2021
2	Bacterial Infections (Bacterial Infection) 03/2022 - 01/2017
2	COVID-19 01/2022 - 12/2020
2	Pain (Aches) 11/2021 - 01/2021
2	Neuralgia (Stump Neuralgia) 11/2021 - 01/2021
2	Colitis 09/2021 - 08/2021
2	Acromegaly 01/2021 - 01/2020
2	Osteosarcoma (Osteogenic Sarcoma) 06/2018 - 05/2016
2	Carcinogenesis 01/2018 - 12/2012
2	Corneal Injuries 01/2018 - 01/2018
2	Rheumatoid Arthritis 10/2015 - 02/2015
1	Seizures (Absence Seizure) 11/2022
1	Hypertrophy 07/2022
1	Hyperglycemia 03/2022
1	Sarcopenia 02/2022
1	Liver Neoplasms (Liver Cancer) 02/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022
1	Lymphedema (Milroy Disease) 01/2022
1	Sneezing 12/2021
1	Ulcerative Colitis 09/2021

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2017
9	Proteins (Proteins, Gene)FDA Link 12/2021 - 05/2008
7	Long Noncoding RNAIBA 02/2022 - 12/2012
7	EnzymesIBA 01/2019 - 06/2013
4	Therapeutic UsesIBA 09/2021 - 01/2017
3	Kainic Acid (Kainate)IBA 11/2022 - 01/2018
3	PeriostinIBA 07/2022 - 06/2018
3	CytokinesIBA 03/2022 - 01/2018
3	Messenger RNA (mRNA)IBA 12/2021 - 01/2014
3	MicroRNAs (MicroRNA)IBA 12/2021 - 05/2016
3	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 03/2020 - 01/2017
3	Pharmaceutical PreparationsIBA 01/2020 - 05/2014
3	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2019 - 01/2019
2	AntigensIBA 07/2022 - 12/2021
2	Carcinoembryonic AntigenIBA 07/2022 - 12/2021
2	CarbohydratesIBA 07/2022 - 12/2021
2	Heme (Haem)IBA 05/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2021
2	Circular RNAIBA 12/2021 - 01/2020
2	salicylhydroxamic acid (SHAM)IBA 11/2021 - 01/2021
2	InflammasomesIBA 09/2021 - 10/2019
2	FlavonoidsIBA 09/2021 - 03/2019
2	Urea (Carbamide)FDA LinkGeneric 01/2021 - 06/2017
2	Collagen Type I (Type I Collagen)IBA 11/2020 - 05/2011
2	Carbapenems (Carbapenem Antibiotics)IBA 03/2020 - 01/2017
2	Neuroprotective AgentsIBA 12/2019 - 06/2017
2	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2016
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2018 - 05/2014
2	Biological ProductsIBA 01/2018 - 06/2013
2	Pyruvate KinaseIBA 01/2018 - 11/2017
2	Muramidase (Lysozyme)IBA 02/2016 - 06/2014
2	Dihydroorotate DehydrogenaseIBA 10/2015 - 02/2015
2	3' Untranslated Regions (3' UTR)IBA 12/2011 - 05/2011
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2022
1	Type A Botulinum Toxins (Botox)FDA Link 07/2022
1	Protein CoronaIBA 06/2022
1	BilirubinIBA 02/2022
1	AlbuminsIBA 02/2022
1	lenvatinibIBA 02/2022
1	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2022
1	CarbonIBA 01/2022
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2022
1	tissue polypeptide specific antigenIBA 12/2021
1	Tumor Biomarkers (Tumor Markers)IBA 12/2021
1	Hematoxylin (Haematoxylon)IBA 12/2021
1	Forkhead Box Protein O1IBA 12/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2021
1	UbiquitinIBA 12/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2021
1	perforin-granzyme BIBA 10/2021
1	Hormones (Hormone)IBA 10/2021
1	veronicastrosideIBA 09/2021
1	Histone MethyltransferasesIBA 09/2021
1	Enhancer of Zeste Homolog 2 ProteinIBA 09/2021
1	costunolideIBA 08/2021

Therapy/Procedure

9	Therapeutics 01/2022 - 12/2015
2	Aftercare (After-Treatment) 12/2021 - 01/2021
2	Transcranial Magnetic Stimulation 11/2021 - 01/2021
2	Oral Administration 08/2021 - 06/2017
2	Drug Therapy (Chemotherapy) 06/2017 - 06/2013
1	Transplantation 01/2022
1	Immunotherapy 01/2022
1	Activities of Daily Living (ADL) 01/2022